Navigation Links
Facet Solutions' AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
Date:10/22/2007

LOGAN, Utah, Oct. 22 /PRNewswire/ -- Facet Solutions, Inc. announced today that testing conducted by Professor Vijay Goel, PhD., from the Department of Bioengineering at the University of Toledo, demonstrated that the Anatomic Facet Replacement System (AFRS(TM)) has shown biomechanical advantages when compared to dynamic stabilization devices. The objective of the testing was to compare the range of motion, pedicle screw stresses, and spinal stability of facet joint replacement versus dynamic stabilization devices.

An experimentally validated computer model of the spine implanted with the AFRS(TM) demonstrated reduced stresses in the pedicle screws supporting the implant. In addition, the results showed improved motion and structural support to the spine.

"Three inherent characteristics of the AFRS(TM) are thought to contribute to these positive results," stated Professor Goel. "These characteristics are: the anatomic implant design, the unconstrained range of motion, and the replacement of diseased bone with a cobalt chrome implant. Additional testing will be conducted to determine the impact that the AFRS(TM) will have on disc pressures when implanted in the spine."

When treating patients with low back pain, one of the most important concerns for a spine surgeon is how to stabilize the spine after performing a spinal decompression (removal of bone around inflamed nerve roots). In the past, the only option available was a spinal fusion. However, a fusion eliminates motion and may cause the joints adjacent to the fusion to degenerate more quickly. These concerns lead to the development of motion preservation devices like dynamic stabilization and facet joint replacement. Dynamic stabilization is an adjunct to fusion and typically utilizes preloaded rods and screws to provide controlled motion. By contrast, facet joint replacement allows for unconstrained motion and mimics the natural kinematics, balance, and stability in the spine joints; si
'/>"/>

SOURCE Facet Solutions
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine technology :

1. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
2. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...lobalMarketPerspective ,, http://www.reportl...l-Market-Perspective.html ,, Risingincidenceof...onsisaprincipalfactorinfluencinggrowthinthemammogr...cancerhasallowedwomentocomeforwardfortheiryearlyma...
(Date:11/25/2009)...dingtoMillenniumResearchGroup(MRG),theglobalauthor...$3billionUSmarketfortraumafixationdeviceswillconti...ecenteconomicslowdown.MRG,s USMarketsforTraumaDevi...ydynamicoverthenextfiveyears,withcompetitorsintrod...entsofthetraumafixationmarket,fuelingmarketgrowth....
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...ends ,, http://www.reportlinker.com/p0164220...preadavailabilityofgenericdrugs,emergenceofpainman...edthepaceofgrowthinthepainmanagementmarket.Healthc...demandforservices,drugsanddevices.Themarketisprima...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Health Care Reform Could Be Obamas Toughest Challenge 49596 1Health Care Reform Could Be Obamas Toughest Challenge 49596 2Health Care Reform Could Be Obamas Toughest Challenge 49596 3Health Care Reform Could Be Obamas Toughest Challenge 49596 4Sechrist Industries Introduces Ground Check System to Verify NFPA Ground Requirements in Hyperbaric Chambers 49593 1Sechrist Industries Introduces Ground Check System to Verify NFPA Ground Requirements in Hyperbaric Chambers 49593 2Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 1Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 2Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 49590 3
...Showed Larazotide Acetate Prevented Immunologic Ch...s with Celiac Disease, Additional Data Indicates P...ORLANDO, Fla., Oct. 7 Alba Therapeutics Corporati...s week at the American,College of Gastroenterology...tudy CLIN 1001-004, the first Phase IIa trial cond...
...DGE, Mass., Oct. 7 Taligen Therapeutics Inc.,toda...mpany,s pipeline,candidates were presented at the ...witzerland. The data highlighted the candidates, e...iated diseases., "These highlighted presentations... the conference, reveal the deep expertise and exp...
Other Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4
(Date:11/25/2009)...calEndorsements,Business,andPressJoinEfforttoEduca...re/--Onceagain,theNationalBipolarFoundationandtheM...eir"Safe,tilStable"program,whichisnowbeingwidelyac...rder.Today,theNationalBipolarFoundationreceivedapr...ilfromtheLt.GovernorofLouisianaMitchLandrieu.TheNa...
(Date:11/25/2009)...ound evidence of a statistically significant survi... whose estrogen receptor (ER)-positive tumors had ...ine-118 (ER-alpha S118-P), according to a brief co...ournal of the National Cancer Institute . , Appr...o tamoxifen. Preclinical studies have shown that E...
(Date:11/25/2009)...se blood pressure? This simple question has been ... Stress-related gene Modulates High Blood Pressure...re? This simple question has been the focus of in...as for the first time established a link between a...ponse to stress in mice as well as humans. The stu...
(Date:11/25/2009)...sed to fight rheumatoid arthritis, could help newl...EDNESDAY, Nov. 25 (HealthDay News) -- A drug commo...atoid arthritis now also shows some promise in hel.... , The drug, rituximab (Rituxan), helped patie... though the disease had destroyed some of their pa...
(Date:11/25/2009)...ss could lead mothers to overlook needed care, stu...ay News) -- A mother,s depression can worsen her c...heir six-month study of 262 black mothers and thei...ore depressive symptoms had more frequent asthma s...essive symptoms had less frequent asthma symptoms....
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2
... Reynolds American,Inc. (NYSE: RAI ) will webcast...d-quarter 2008 financial results on Wednesday, Oct... Time., During the call, members of the Reynolds ...le online on a listen-only basis,at http://www.Re...
... "air burial," grave cairns, funeral mounds, mummi...ces sacred to one culture are often considered "od... example, were fascinated with the historian Herod...ontrary to the Greeks, treatment of their own dead...
...al concerns surrounding use of cells from embryos ...European researchers say they,ve figured out how t...onic-like stem cells. , The findings are the lates...acles associated with their use. , "The ability to...
...The National,Community Pharmacists Association (NC...-term incumbent representing North Carolina, for r... executive vice president and CEO of,NCPA, issued ...serve. That is why the,National Community Pharmaci...
...The National,Community Pharmacists Association (NC...m incumbent representing Arkansas, for re-election... vice president and CEO of NCPA,issued the followi...e National,Community Pharmacists Association stron...
...The National,Community Pharmacists Association (NC...rm incumbent representing Kansas, for re-election ...vice president and CEO of NCPA,issued the followin...National,Community Pharmacists Association strongl...
Other Medicine News:Health News:RAI to Webcast Third-Quarter 2008 Earnings Conference Call 2Health News:Deathways open doors to unexpected cultural practices 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 3Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 4
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
Medicine Products: